Brazil Animal Biotechnology Market Size & Outlook, 2030

Revenue, 2022 (US$M)

$0.0

Forecast, 2030 (US$M)

$0.0

CAGR, 2023 - 2030

Report Coverage

Brazil

Brazil animal biotechnology market, 2018-2030 (US$M)

Related Markets

Global Animal Biotechnology Industry

North America Animal Biotechnology Market Outlook

Europe Animal Biotechnology Market Outlook

Asia Pacific Animal Biotechnology Market Outlook

Latin America Animal Biotechnology Market Outlook

MEA Animal Biotechnology Market Outlook

Brazil animal biotechnology market highlights

The Brazil animal biotechnology market generated a revenue of USD 791.8 million in 2022 and is expected to reach USD 1,668.0 million by 2030.
The Brazil market is expected to grow at a CAGR of 9.8% from 2023 to 2030.
In terms of segment, vaccines was the largest revenue generating product in 2022.
Diagnostics Tests is the most lucrative product segment registering the fastest growth during the forecast period.

Animal biotechnology market data book summary

Market revenue in 2022	USD 791.8 million
Market revenue in 2030	USD 1,668.0 million
Growth rate	9.8% (CAGR from 2022 to 2030)
Largest segment	Vaccines
Fastest growing segment	Diagnostics Tests
Historical data	2018 - 2021
Base year	2022
Forecast period	2023 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Diagnostics Tests, Vaccines, Drugs, Reproductive And Genetic, Feed Additives
Key market players worldwide	Zoetis Inc Class A, Boehringer Ingelheim, Biogenesis Bago, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Hester Biosciences, Kareo, NXGN

Other key industry trends

In terms of revenue, Brazil accounted for 3.3% of the global animal biotechnology market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Brazil animal biotechnology market is projected to lead the regional market in terms of revenue in 2030.
Mexico is the fastest growing regional market in Latin America and is projected to reach USD 1,476.1 million by 2030.

Key Regions: U.S. , UK , Japan , Canada , Germany

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Animal Biotechnology Market Scope

Animal biotechnology market segmentation & scope

Product

Diagnostics Tests

Vaccines

Drugs

Reproductive And Genetic

Feed Additives

Application

Diagnosis of Animal Diseases

Treatment of Animal Diseases

Preventive Care of Animals

Drug Development

Others

Animal Type

Livestock

Poultry

Swine

Cattle

Sheep & Goats

Fish

Companion

Dogs

Cats

Horses

Others

End Use

Laboratories

Point-of-care testing/In-house testing

Veterinary Hospitals & Clinics

Others

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Germany

France

Italy

Spain

Japan

China

India

Australia

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

Animal Biotechnology Market Companies

Name	Profile	# Employees	HQ	Website

Brazil animal biotechnology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal biotechnology market will help companies and investors design strategic landscapes.

Vaccines was the largest segment with a revenue share of 23.12% in 2022. Horizon Databook has segmented the Brazil animal biotechnology market based on diagnostics tests, vaccines, drugs, reproductive and genetic, feed additives covering the revenue growth of each sub-segment from 2018 to 2030.

Reasons to subscribe to Brazil animal biotechnology market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil animal biotechnology market databook

Our clientele includes a mix of animal biotechnology market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil animal biotechnology market, including forecasts for subscribers. This country databook contains high-level insights into Brazil animal biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list